BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Kim JY, Kim HJ, Park JH, Park DI, Cho YK, Sohn CI, Jeon WK, Kim BI, Kim DH, Chae SW, Sohn JH. Epidermal growth factor upregulates Skp2/Cks1 and p27kip1 in human extrahepatic cholangiocarcinoma cells. World J Gastroenterol 2014; 20(3): 755-773 [PMID: 24574749 DOI: 10.3748/wjg.v20.i3.755]
URL: https://www.wjgnet.com/1007-9327/full/v20/i3/755.htm
Number Citing Articles
1
Qingzeng Qian, Qinghua Ma, Bin Wang, Qingqiang Qian, Changsong Zhao, Fumin Feng, Xiaona Dong. MicroRNA‐205‐5p targets E2F1 to promote autophagy and inhibit pulmonary fibrosis in silicosis through impairing SKP2‐mediated Beclin1 ubiquitinationJournal of Cellular and Molecular Medicine 2021; 25(19): 9214 doi: 10.1111/jcmm.16825
2
Arthur Zimmermann. Tumors and Tumor-Like Lesions of the Hepatobiliary Tract2016; : 1 doi: 10.1007/978-3-319-26587-2_174-1
3
Rocio I R Macias, Vincenzo Cardinale, Timothy J Kendall, Matias A Avila, Maria Guido, Cedric Coulouarn, Chiara Braconi, Adam E Frampton, John Bridgewater, Diletta Overi, Stephen P Pereira, Marco Rengo, Jakob N Kather, Angela Lamarca, Federica Pedica, Alejandro Forner, Juan W Valle, Eugenio Gaudio, Domenico Alvaro, Jesus M Banales, Guido Carpino. Clinical relevance of biomarkers in cholangiocarcinoma: critical revision and future directionsGut 2022; : gutjnl-2022-327099 doi: 10.1136/gutjnl-2022-327099
4
Yan Lv, Yun Niu, Chong Li, Xu Zheng, Qiang Geng, Yanyan Han. Aberrant Level of Skp2 and p27KIP1 in Intraductal Proliferative Lesions is Associated with TumorigenesisCancer Investigation 2017; 35(6): 414 doi: 10.1080/07357907.2017.1301465
5
Rocio I. R. Macias, Miroslaw Kornek, Pedro M. Rodrigues, Nuno A. Paiva, Rui E. Castro, Sabine Urban, Stephen P. Pereira, Massimiliano Cadamuro, Christian Rupp, Sven H. Loosen, Tom Luedde, Jesus M. Banales. Diagnostic and prognostic biomarkers in cholangiocarcinomaLiver International 2019; 39(S1): 108 doi: 10.1111/liv.14090
6
Christian Mayr, Andrej Wagner, Magdalena Loeffelberger, Daniela Bruckner, Martin Jakab, Frieder Berr, Pietro Di Fazio, Matthias Ocker, Daniel Neureiter, Martin Pichler, Tobias Kiesslich. The BMI1 inhibitor PTC-209 is a potential compound to halt cellular growth in biliary tract cancer cellsOncotarget 2016; 7(1): 745 doi: 10.18632/oncotarget.6378
7
Arthur Zimmermann. Tumors and Tumor-Like Lesions of the Hepatobiliary Tract2017; : 3173 doi: 10.1007/978-3-319-26956-6_174